Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Regeneron Pharmaceuticals Inc (REGN)

2014-10-25@06:51:33 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-10-24@15:29:39 ET
Shares of Regeneron Pharmaceuticals Rise to a New 52-Week High (F71)

2014-10-24@13:44:58 ET
Regeneron Pharmaceuticals (REGN) Showing Bullish Technicals With Resistance At $403.45 (FBM)

2014-10-23@17:34:21 ET
Look for Shares of Regeneron Pharmaceuticals to Potentially Pullback after Yesterday's 2.46% Rise (PSM)

2014-10-23@14:51:16 ET
Potential Regeneron Pharmaceuticals (REGN) Trade Has 6.11% Downside Protection (FBM)

2014-10-23@09:20:00 ET
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent (PRN)

2014-10-23@01:30:55 ET
Regeneron announces encouraging results from diabetic macular edema study (DTM)

2014-10-22@15:53:33 ET
Regeneron Pharmaceuticals (REGN) Trading Near $361.17 Support Level (FBM)

2014-10-22@15:44:49 ET
Shares of Regeneron Pharmaceuticals Rise Above Previous 52-Week High (F71)

2014-10-21@14:44:32 ET
Stock Investors Bid Up Shares of Regeneron Pharmaceuticals, Up 2.5% (F77)

2014-10-21@10:02:59 ET
Regeneron Genetics announces new collaborations with academic institutions (DTM)

2014-10-21@06:01:52 ET
Quorum Review's Linda Coleman to Present at MAGI West 2014 (PRW)

2014-10-21@05:39:29 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-10-21@05:15:24 ET
Regeneron and Sanofi announce first-patient dosing in Phase III AD study (DTM)

2014-10-21@01:55:50 ET
Regeneron Earns Top Spot as Employer in the Global Biopharmaceutical Industry (CLM)

2014-10-20@11:50:04 ET
Regeneron Pharmaceuticals (REGN) Showing Bullish Technicals With Resistance At $384.37 (FBM)

2014-10-20@09:00:00 ET
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma (PRN)